How will the legislation of Integrated Care Systems in July 2022, and the ‘New NHS’ impact on Pharma market access? NHS England is going through its most significant changes for...
Read More
People, pathways, and payments – Mastering the key pillars of NHS engagement in 2023 Pharma and Medtech market access professionals joined us and our guest speakers from across the NHS...
Read More
What roles and responsibilities do Clinical Pharmacists have in the NHS? How can Pharma and Medtech engage Clinical Pharmacists, and how can industry best support these new decision-makers? In this...
Read More
Specialised services have long been the subject of debate around their place in Integrated Care Systems (ICSs), who will run them and how will they be funded. On 31st May...
Read More
As the NHS takes steps towards a more integrated future, how are systems and care pathways transforming? How is change being implemented, and what does this look like in reality...
Read More
On 13th April NHS England published the initial 2022/23 budgets of the 42 Integrated Care Boards (ICBs) expected to go live from 1st July 2022, subject to legislative approval. The...
Read More
NHS England published its 2022/23 National Tariff Payment System on 31st March 2022, a day before the new NHS financial year. The system provides guidance for the continued running of...
Read More
What does population health management mean for the NHS, for patients, and for industry? How will the NHS translate population health management into impactful service change and what will this...
Read More
Planning in a volatile environment: how will the NHS reconcile its competing priorities and operational planning to meet its challenges? What does the ‘2022/23 priorities and operational planning guidance’ document...
Read More
In the lead up to Christmas 2021, our UK market access team shared a daily insight, reflection, or comment on the NHS and the UK market access environment on our...
Read More